GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kanabo Group PLC (LSE:KNB) » Definitions » ROCE %

Kanabo Group (LSE:KNB) ROCE % : -124.46% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Kanabo Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Kanabo Group's annualized ROCE % for the quarter that ended in Dec. 2023 was -124.46%.


Kanabo Group ROCE % Historical Data

The historical data trend for Kanabo Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kanabo Group ROCE % Chart

Kanabo Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial -42.08 -177.32 -176.91 -75.13 -77.16

Kanabo Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -113.45 -53.01 -42.49 -17.07 -124.46

Kanabo Group ROCE % Calculation

Kanabo Group's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-7.946/( ( (14.452 - 1.497) + (8.351 - 0.71) )/ 2 )
=-7.946/( (12.955+7.641)/ 2 )
=-7.946/10.298
=-77.16 %

Kanabo Group's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=-13.576/( ( (14.772 - 0.597) + (8.351 - 0.71) )/ 2 )
=-13.576/( ( 14.175 + 7.641 )/ 2 )
=-13.576/10.908
=-124.46 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kanabo Group  (LSE:KNB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Kanabo Group ROCE % Related Terms

Thank you for viewing the detailed overview of Kanabo Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kanabo Group (LSE:KNB) Business Description

Traded in Other Exchanges
Address
137-139 Brent Street, Churchill House, London, GBR, NW4 4DJ
Kanabo Group PLC is a research and development company engaged in selling a range of THC-Free retail CBD products in the markets and it is in the process of developing medical cannabis products. Its reportable segments include Primary Care and Secondary Care. The Primary Care segment includes Tele pharma services provided by GPS and The Secondary Care segment includes the development and distribution of cannabis-derived medical and wellness products. Geographically company has a presence in the United Kingdom, Israel, and others.

Kanabo Group (LSE:KNB) Headlines

No Headlines